Growth investment of €21.5M to expand Dawn Health's AI-enabled patient companion platform. Investors named in coverage include Cipio Partners and existing owner Chr. Augustinus Fabrikker; article references other unnamed existing owners. Company focuses on SaMD, Digital Therapeutics, and regulated digital health solutions for pharma.
About Dawn Health
AI-enabled patient companion platform for pharmaceutical companies supporting disease management, therapy, and clinical research; focuses on regulated digital health (SaMD, Digital Therapeutics, connected health).
Kopenhagen, Denmark
Read Company ProfileFrequently Asked Questions
What type of funding round did Dawn Health raise?
Dawn Health raised a unspecified round.
How much did Dawn Health raise in its unspecified?
Dawn Health raised $21,500,000 EUR in its unspecified.
When did Dawn Health raise its unspecified?
Dawn Health raised its unspecified on 2026-02-11.
Who invested in Dawn Health's unspecified?
The investors in Dawn Health's unspecified are: Cipio Partners, Chr. Augustinus Fabrikker (CAF).
What type of investment was Dawn Health's unspecified?
Dawn Health's unspecified was a equity investment.
How will Dawn Health use the funds from its unspecified?
Dawn Health plans to use the funds for: expand AI-enabled pharma partnerships, accelerate product development, strengthen partnerships with pharma, technology, and AI companies, expand into clinical trial space.